According to ImmunoGen 's latest financial reports the company's total assets are C$1.16 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | C$0.47 B | -29.34% |
2021-12-31 | C$0.67 B | 48% |
2020-12-31 | C$0.45 B | 47.35% |
2019-12-31 | C$0.30 B | -23.64% |
2018-12-31 | C$0.40 B | 8.61% |
2017-12-31 | C$0.37 B | |
2016-06-30 | C$0.36 B | -5.6% |
2015-06-30 | C$0.38 B | 116.99% |
2014-06-30 | C$0.17 B | -21.53% |
2013-06-30 | C$0.22 B | 22.39% |
2012-06-30 | C$0.18 B | -12.8% |
2011-06-30 | C$0.21 B | 44.41% |
2010-06-30 | C$0.14 B | 24.58% |
2009-06-30 | C$0.11 B | 37.77% |
2008-06-30 | C$84.94 M | -0.35% |
2007-06-30 | C$85.24 M | -18.75% |
2006-06-30 | C$0.10 B | -22.21% |
2005-06-30 | C$0.13 B | -17.51% |
2004-06-30 | C$0.16 B | 2.84% |
2003-06-30 | C$0.15 B | -31.07% |
2002-06-30 | C$0.23 B | -4.34% |
2001-06-30 | C$0.24 B |